Literature DB >> 22711710

The quest for self-identity: not all cancer stem cells are the same.

Anita B Hjelmeland1, Jeremy N Rich.   

Abstract

A central critique of the cancer stem cell (CSC) hypothesis involves the robustness of CSC markers. Zorniak and colleagues suggest that different progenitor marker profiles can classify CSCs, and improved modeling of cellular hierarchies can be achieved by incorporating inter- and intratumoral diversity. ©2012 AACR.

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22711710      PMCID： PMC3389128          DOI： 10.1158/1078-0432.CCR-12-1456

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN： 1078-0432            Impact factor:   12.531


  12 in total

Review 1.  Stem cells, cancer, and cancer stem cells.

Authors:  T Reya; S J Morrison; M F Clarke; I L Weissman
Journal:  Nature       Date:  2001-11-01       Impact factor: 49.962

2.  CNP is required for maintenance of axon-glia interactions at nodes of Ranvier in the CNS.

Authors:  Matthew N Rasband; Jane Tayler; Yoshimi Kaga; Yang Yang; Corinna Lappe-Siefke; Klaus-Armin Nave; Rashmi Bansal
Journal:  Glia       Date:  2005-04-01       Impact factor: 7.452

3.  A distinct subset of glioma cell lines with stem cell-like properties reflects the transcriptional phenotype of glioblastomas and overexpresses CXCR4 as therapeutic target.

Authors:  Alexander Schulte; Hauke S Günther; Heidi S Phillips; Dirk Kemming; Tobias Martens; Samir Kharbanda; Robert H Soriano; Zora Modrusan; Svenja Zapf; Manfred Westphal; Katrin Lamszus
Journal:  Glia       Date:  2011-02-03       Impact factor: 7.452

4.  Gene expression profiling and genetic markers in glioblastoma survival.

Authors:  Jeremy N Rich; Christopher Hans; Beatrix Jones; Edwin S Iversen; Roger E McLendon; B K Ahmed Rasheed; Adrian Dobra; Holly K Dressman; Darell D Bigner; Joseph R Nevins; Mike West
Journal:  Cancer Res       Date:  2005-05-15       Impact factor: 12.701

5.  Human CD271-positive melanoma stem cells associated with metastasis establish tumor heterogeneity and long-term growth.

Authors:  Gianluca Civenni; Anne Walter; Nikita Kobert; Daniela Mihic-Probst; Marie Zipser; Benedetta Belloni; Burkhardt Seifert; Holger Moch; Reinhard Dummer; Maries van den Broek; Lukas Sommer
Journal:  Cancer Res       Date:  2011-03-10       Impact factor: 12.701

6.  Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1.

Authors:  Roel G W Verhaak; Katherine A Hoadley; Elizabeth Purdom; Victoria Wang; Yuan Qi; Matthew D Wilkerson; C Ryan Miller; Li Ding; Todd Golub; Jill P Mesirov; Gabriele Alexe; Michael Lawrence; Michael O'Kelly; Pablo Tamayo; Barbara A Weir; Stacey Gabriel; Wendy Winckler; Supriya Gupta; Lakshmi Jakkula; Heidi S Feiler; J Graeme Hodgson; C David James; Jann N Sarkaria; Cameron Brennan; Ari Kahn; Paul T Spellman; Richard K Wilson; Terence P Speed; Joe W Gray; Matthew Meyerson; Gad Getz; Charles M Perou; D Neil Hayes
Journal:  Cancer Cell       Date:  2010-01-19       Impact factor: 31.743

7.  Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis.

Authors:  Heidi S Phillips; Samir Kharbanda; Ruihuan Chen; William F Forrest; Robert H Soriano; Thomas D Wu; Anjan Misra; Janice M Nigro; Howard Colman; Liliana Soroceanu; P Mickey Williams; Zora Modrusan; Burt G Feuerstein; Ken Aldape
Journal:  Cancer Cell       Date:  2006-03       Impact factor: 31.743

8.  Neurosphere formation is an independent predictor of clinical outcome in malignant glioma.

Authors:  Dan R Laks; Michael Masterman-Smith; Koppany Visnyei; Brigitte Angenieux; Nicholas M Orozco; Ian Foran; William H Yong; Harry V Vinters; Linda M Liau; Jorge A Lazareff; Paul S Mischel; Timothy F Cloughesy; Steve Horvath; Harley I Kornblum
Journal:  Stem Cells       Date:  2009-04       Impact factor: 6.277

9.  Cyclopamine-mediated hedgehog pathway inhibition depletes stem-like cancer cells in glioblastoma.

Authors:  Eli E Bar; Aneeka Chaudhry; Alex Lin; Xing Fan; Karisa Schreck; William Matsui; Sara Piccirillo; Angelo L Vescovi; Francesco DiMeco; Alessandro Olivi; Charles G Eberhart
Journal:  Stem Cells       Date:  2007-07-12       Impact factor: 6.277

10.  Differential expression of 2',3'-cyclic-nucleotide 3'-phosphodiesterase and neural lineage markers correlate with glioblastoma xenograft infiltration and patient survival.

Authors:  Michael Zorniak; Paul A Clark; Heather E Leeper; Matthew D Tipping; David M Francis; Kevin R Kozak; M Shahriar Salamat; John S Kuo
Journal:  Clin Cancer Res       Date:  2012-05-15       Impact factor: 12.531
View more
  7 in total

1.  Immunobiology and signaling pathways of cancer stem cells: implication for cancer therapy.

Authors:  Mohamed L Salem; Ahmed S El-Badawy; Zihai Li
Journal:  Cytotechnology       Date:  2014-12-17       Impact factor: 2.058

Review 2.  Cancer Stem Cell Quiescence and Plasticity as Major Challenges in Cancer Therapy.

Authors:  Wanyin Chen; Jihu Dong; Jacques Haiech; Marie-Claude Kilhoffer; Maria Zeniou
Journal:  Stem Cells Int       Date:  2016-06-21       Impact factor: 5.443

Review 3.  Cancer Stem Cells Are Possible Key Players in Regulating Anti-Tumor Immune Responses: The Role of Immunomodulating Molecules and MicroRNAs.

Authors:  Sara Tomei; Ola Ibnaof; Shilpa Ravindran; Soldano Ferrone; Cristina Maccalli
Journal:  Cancers (Basel)       Date:  2021-04-02       Impact factor: 6.575

Review 4.  The Molecular and Microenvironmental Landscape of Glioblastomas: Implications for the Novel Treatment Choices.

Authors:  Federica Di Cintio; Michele Dal Bo; Lorena Baboci; Elena De Mattia; Maurizio Polano; Giuseppe Toffoli
Journal:  Front Neurosci       Date:  2020-11-25       Impact factor: 4.677

5.  Cannabidiol inhibits RAD51 and sensitizes glioblastoma to temozolomide in multiple orthotopic tumor models.

Authors:  Liliana Soroceanu; Eric Singer; Pratiksha Dighe; Max Sidorov; Chandani Limbad; Aida Rodriquez-Brotons; Peter Rix; Rinette W L Woo; Lawrence Dickinson; Pierre-Yves Desprez; Sean D McAllister
Journal:  Neurooncol Adv       Date:  2022-02-17

6.  Cancer-initiating cells from colorectal cancer patients escape from T cell-mediated immunosurveillance in vitro through membrane-bound IL-4.

Authors:  Andrea Volonté; Tiziano Di Tomaso; Michela Spinelli; Matilde Todaro; Francesca Sanvito; Luca Albarello; Massimiliano Bissolati; Luca Ghirardelli; Elena Orsenigo; Soldano Ferrone; Claudio Doglioni; Giorgio Stassi; Paolo Dellabona; Carlo Staudacher; Giorgio Parmiani; Cristina Maccalli
Journal:  J Immunol       Date:  2013-11-25       Impact factor: 5.422

7.  Cancer stem cell markers in head and neck squamous cell carcinoma.

Authors:  Aidan G Major; Luke P Pitty; Camile S Farah
Journal:  Stem Cells Int       Date:  2013-03-03       Impact factor: 5.443
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.